ChenGuang Biotech Group Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Qingguo Lu
Chief executive officer
CN¥2.1m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | 21.3% |
| Management average tenure | no data |
| Board average tenure | 1.6yrs |
Recent management updates
Recent updates
A Piece Of The Puzzle Missing From ChenGuang Biotech Group Co., Ltd.'s (SZSE:300138) 43% Share Price Climb
Oct 08
ChenGuang Biotech Group (SZSE:300138) Might Be Having Difficulty Using Its Capital Effectively
Sep 30Return Trends At ChenGuang Biotech Group (SZSE:300138) Aren't Appealing
May 13Impressive Earnings May Not Tell The Whole Story For ChenGuang Biotech Group (SZSE:300138)
Apr 25ChenGuang Biotech Group Co., Ltd. (SZSE:300138) Just Reported, And Analysts Assigned A CN¥17.66 Price Target
Apr 21CEO
Qingguo Lu (65 yo)
no data
Tenure
CN¥2,118,500
Compensation
Mr. Qingguo Lu is Chairman & GM of ChenGuang Biotech Group Co., Ltd.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & GM | no data | CN¥2.12m | 21.3% CN¥ 908.6m | |
| CFO, Secretary of the Board & Director | 5.7yrs | CN¥678.00k | 1.71% CN¥ 73.1m | |
| Employee Representative Supervisor | no data | no data | 0.011% CN¥ 467.5k | |
| Non-Independent Director | 1.6yrs | CN¥3.97m | no data | |
| Supervisory Board Chairman | no data | CN¥652.40k | 0.015% CN¥ 655.2k | |
| Non Employee Representative Supervisor | no data | no data | no data | |
| Independent Director | 1.6yrs | CN¥49.00k | no data | |
| Independent Director | 1.6yrs | CN¥49.00k | no data | |
| Independent Director | 1.6yrs | CN¥49.00k | no data |
1.6yrs
Average Tenure
44yo
Average Age
Experienced Board: 300138's board of directors are not considered experienced ( 1.6 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/25 15:31 |
| End of Day Share Price | 2024/12/25 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
ChenGuang Biotech Group Co., Ltd. is covered by 7 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Siyuan Dong | Changjiang Securities Co. LTD. |
| Wendan Wang | China International Capital Corporation Limited |
| Guang Yao Chen | Founder Securities Co., Ltd. |